ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,277 | +35.6% | 47,527 | +28.2% | 0.11% | +17.2% |
| Q1 2023 | $942 | -99.8% | 37,073 | +223.9% | 0.09% | +86.0% |
| Q3 2022 | $378,000 | -64.5% | 11,447 | -62.1% | 0.05% | -68.8% |
| Q2 2022 | $1,065,000 | +104.0% | 30,241 | +166.5% | 0.16% | +128.6% |
| Q1 2022 | $522,000 | +141.7% | 11,346 | +51.1% | 0.07% | +29.6% |
| Q1 2020 | $216,000 | -22.6% | 7,511 | +70.7% | 0.05% | +68.8% |
| Q4 2019 | $279,000 | +3.0% | 4,400 | -54.2% | 0.03% | -13.5% |
| Q3 2019 | $271,000 | -71.4% | 9,600 | -73.2% | 0.04% | -65.1% |
| Q2 2019 | $949,000 | -25.7% | 35,800 | -48.6% | 0.11% | -17.8% |
| Q1 2019 | $1,277,000 | +408.8% | 69,613 | +244.3% | 0.13% | +344.8% |
| Q4 2018 | $251,000 | -74.0% | 20,217 | -84.9% | 0.03% | -43.1% |
| Q1 2018 | $966,000 | – | 133,969 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |